|
Listen to this text  |
CMR Surgical as we speak introduced it has put in greater than 100 Versius surgical robotic methods worldwide. Count CMR amongst a bunch of corporations, large and small, which can be searching for to compete in opposition to surgical robotics pioneer Intuitive.
Since introducing Versius in 2019, Cambridge, U.Ok.–primarily based CMR has scaled up quickly. There are actually Versius robots in operation throughout Europe, Asia, Australia, Latin America, and the Middle East.
To meet the rising demand, CMR Surgical is engaged on constructing a roughly 75,000-square-foot manufacturing facility in Cambridgeshire. The new facility will function CMR’s world manufacturing hub. The firm additionally has plans for extra European places of work within the coming months.
CMR Surgical CEO Per Vegard Nerseth described the 100 Versius methods put in as a big milestone for the corporate.
“We have seen strong and growing demand for Versius across the world in the last year as both public health systems and private centers increasingly recognize the value in a small, modular and portable system,” Nerseth mentioned. “A key focus for us is always on finding the right partners, and we are proud to be partnering with world-class hospitals and surgeons, many of which could not previously adopt a surgical robot.”
The Versius system options freedom of port placement. The function permits procedures tailor-made to the wants of every affected person. Surgeons can function the best way they did laparoscopically, however with the advantages of robotic surgical procedure, in line with the corporate. Versius has a small, light-weight and modular design that may be moved “effortlessly.”
Health suppliers have used Versius in additional than 5,000 medical circumstances throughout 128 process sorts. The system has discovered use in specialties together with gynecology, colorectal surgical procedure, thoracic surgical procedure, basic surgical procedure and urology.
Since it was based in 2014, CMR Surgical has raised almost $1 billion in funding. Its final funding spherical got here in June 2021 when it closed a $600 million Series D spherical that was led by the SoftBank Vision Fund 2ii.
Editor’s Note: This article first appeared on sister publication Mass Device and was republished with permission.